摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-tert-butyl-6-bromo-7-methylimidazolo[1,2-a]pyrimid-5-one | 335278-67-6

中文名称
——
中文别名
——
英文名称
2-tert-butyl-6-bromo-7-methylimidazolo[1,2-a]pyrimid-5-one
英文别名
5-bromo-6-methyl-2-(tert-butyl)-7H-imidazolo[1,2-a]pyrimid-4-one;6-bromo-2-tert-butyl-7-methyl-1H-imidazo[1,2-a]pyrimidin-5-one
2-tert-butyl-6-bromo-7-methylimidazolo[1,2-a]pyrimid-5-one化学式
CAS
335278-67-6
化学式
C11H14BrN3O
mdl
——
分子量
284.156
InChiKey
UGZCLLWWCMMIRP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    44.7
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Design and Structure−Activity Relationships of 2-Alkyl-3-aminomethyl-6-(3-methoxyphenyl)-7-methyl-8-(2-fluorobenzyl)imidazolo[1,2-a]pyrimid-5-ones as Potent GnRH Receptor Antagonists
    摘要:
    SAR studies of 7-phenylpyrrolo[1,2-a]pyrimid-4-ones 1 and 2, and 2-phenylimidazolo[1,2-a]-pyrimidines 3 and 4, as nonpeptide human GnRH receptor antagonists, lead us to believe that the aromatic ring at position-2 of 4 is no longer crucial for the binding once an aryl group is incorporated at postion-6. We report here the use of a 2-alkyl group on the imidazolo[1,2-a]-pyrimidone core to generate potent GnRH receptor antagonists. This discovery enabled us to obtain smaller but equally potent GnRH receptor antagonists.
    DOI:
    10.1021/jm0205402
  • 作为产物:
    描述:
    1-溴频哪酮2-氨基-5-溴-4-羟基-6-甲基嘧啶N,N-二甲基甲酰胺丙酮 、 mineral oil 为溶剂, 以80%的产率得到2-tert-butyl-6-bromo-7-methylimidazolo[1,2-a]pyrimid-5-one
    参考文献:
    名称:
    Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
    摘要:
    GnRH受体拮抗剂被披露出来,对男性和女性的各种与性激素相关的疾病具有治疗作用。本发明的化合物具有以下结构:其中Ar、A、B、Q、R1、R2、R3a、R3b、R6、R7和m的定义如本文所述,包括立体异构体、前药和其药用可接受盐。还披露了含有本发明化合物的组合物,与药用可接受载体结合,以及与其相关的用于拮抗需要者体内促性腺激素释放激素的方法。
    公开号:
    US06537998B1
点击查看最新优质反应信息

文献信息

  • Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
    申请人:Neurocrine Biosciences, Inc.
    公开号:US06537998B1
    公开(公告)日:2003-03-25
    GnRH receptor antagonists are disclosed which have utility in the treatment of a variety of sex-hormone related conditions in both men and women. The compounds of this invention have the structure: wherein Ar, A, B, Q, R1, R2, R3a, R3b, R6, R7 and m are as defined herein, including stereoisomers, prodrugs and pharmaceutical acceptable salts thereof. Also disclosed are compositions containing a compound of this invention in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for antagonizing gonadotropin-releasing hormone in a subject in need thereof.
    GnRH受体拮抗剂被披露出来,对男性和女性的各种与性激素相关的疾病具有治疗作用。本发明的化合物具有以下结构:其中Ar、A、B、Q、R1、R2、R3a、R3b、R6、R7和m的定义如本文所述,包括立体异构体、前药和其药用可接受盐。还披露了含有本发明化合物的组合物,与药用可接受载体结合,以及与其相关的用于拮抗需要者体内促性腺激素释放激素的方法。
  • GONADOTROPIN RELEASING HORMONE RECEPTOR ANTAGONISTS AND THEIR RELATED METHODS OF USE
    申请人:NEUROCRINE BIOSCIENCES, INC.
    公开号:EP1220857B1
    公开(公告)日:2005-09-21
  • Design and Structure−Activity Relationships of 2-Alkyl-3-aminomethyl-6-(3-methoxyphenyl)-7-methyl-8-(2-fluorobenzyl)imidazolo[1,2-<i>a</i>]pyrimid-5-ones as Potent GnRH Receptor Antagonists
    作者:Yun-Fei Zhu、Zhiqiang Guo、Timothy D. Gross、Yinghong Gao、Patrick J. Connors,、R. Scott Struthers、Qiu Xie、Fabio C. Tucci、Greg J. Reinhart、Dongpei Wu、John Saunders、Chen
    DOI:10.1021/jm0205402
    日期:2003.4.1
    SAR studies of 7-phenylpyrrolo[1,2-a]pyrimid-4-ones 1 and 2, and 2-phenylimidazolo[1,2-a]-pyrimidines 3 and 4, as nonpeptide human GnRH receptor antagonists, lead us to believe that the aromatic ring at position-2 of 4 is no longer crucial for the binding once an aryl group is incorporated at postion-6. We report here the use of a 2-alkyl group on the imidazolo[1,2-a]-pyrimidone core to generate potent GnRH receptor antagonists. This discovery enabled us to obtain smaller but equally potent GnRH receptor antagonists.
查看更多